Literature DB >> 20401844

Lateral orbitotomy approach to orbital tumors: report of 10 cases.

Onder Okay1, Ergun Daglioglu, Gokhan Akdemir, Ali Dalgic, Ozhan Uckun, Serkan Atasoy, Deniz Belen.   

Abstract

AIM: Lateral orbitotomy is a well-known approach for lesions of the lateral orbital cone. It is still appropriate for laterally situated tumors although contemporary cranial base approaches were defined and developed within the last decades.
MATERIAL AND METHODS: Here we report 10 orbital lesions operated with lateral orbitotomy, nine of which were extraconal. Cholesterol granuloma, arachnoid cyst, pleomorphic adenoma, malign epithelial tumor, dermoid cyst, inflammatory granuloma and cavernoma were the pathologies encountered.
RESULTS: The extent of lateral orbitotomy should depend on the size, consistency and nature of the lesion for easy removal and less bony resection. In this regard, contrast enhanced CT scans give useful information for operative strategy. The success of surgery can be improved and cosmetic problems can be minimized if meticulous care is taken during orbital rim resection.
CONCLUSION: Although there is a wide range of histopathological diagnosis for orbital tumors, lateral orbitotomy is a safe approach, particularly if the lesions are extraconal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401844     DOI: 10.5137/1019-5149.JTN.2620-09.2

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  3 in total

Review 1.  [Possible surgical approaches to the orbit].

Authors:  H-J Welkoborsky; S K Plontke
Journal:  HNO       Date:  2018-11       Impact factor: 1.284

2.  The Lateral Orbitotomy Approach for Intraorbital Lesions.

Authors:  Ryan P Lee; Adham M Khalafallah; Abhishek Gami; Debraj Mukherjee
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-07

Review 3.  Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region.

Authors:  Priscilla Xinhui Wang; Victor Teck Chang Koh; Katherine Lun; Gangadhara Sundar
Journal:  Int Ophthalmol       Date:  2013-10-02       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.